Clarient Incorporated
News and Blogs
Total : 7 View more »
Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
www.prnewswire.com
Clarient to Present at Upcoming Healthcare Investor Conferences in New York City.
Safeguard Scientifics, Inc. Q3 2009 Earnings Call Transcript
seekingalpha.com | Nov 4, 2009
Safeguard Scientifics, Inc. (SFE)Q3 2009 Earnings Call TranscriptNovember 4, 2009 9:00 am ET<a
Safeguard Scientifics Announces Sale of Approximately One-Third of Its Clarient Shares for Approximately $53 Million in Proceeds, Net of Underwriter Commissions (Business Wire)
finance.yahoo.com | Aug 27, 2009
WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE - News), a holding company that builds value
http://finance.yahoo.com/news/Safeguard-Scientifics-bw-3241467855.html?x=0&.v=1
Clarient to Present at Upcoming Investment Conferences in New York City
news.prnewswire.com
The first presentation will be made at the Rodman & Renshaw 11th Annual Healthcare Conference at 2:50 pm EDT on Wednesday, September 9. The conference is being held at the New York Palace Hotel.
http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-01-2009/0005085823&EDATE=
News from Zibb.com
Total : 39 View more »
Clarient Down 35.8% Since SmarTrend's Sell Recommendation - Zibb.com
Nov 25, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Clarient (NASDAQ:CLRT) on October 12, 2009 at $3.72.
Since then, Clarient has returned 35.8% as of today's recent price of $2.39. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Clarient Inc (CLRT)
Clarient Down 34.1% Since SmarTrend's Sell Recommendation - Zibb.com
Nov 17, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Clarient (NASDAQ:CLRT) on October 12, 2009 at $3.72.
Since then, Clarient has returned 34.1% as of today's recent price of $2.45. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Clarient Inc (CLRT)
Clarient Down 34.9% Since SmarTrend's Sell Recommendation - Zibb.com
Nov 10, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Clarient (NASDAQ:CLRT) on October 12, 2009 at $3.72.
Since then, Clarient has returned 34.9% as of today's recent price of $2.42. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Clarient Inc (CLRT)
Clarient Down 34.1% Since SmarTrend's Sell Recommendation - Zibb.com
Nov 04, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Clarient (NASDAQ:CLRT) on October 12, 2009 at $3.72.
Since then, Clarient has returned 34.1% as of today's recent price of $2.45. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Clarient Inc (CLRT)
Web Sites
Total : 85 View more »
Clarient Reports 41% Revenue Increase for First Quarter 2009
www.bio-medicine.org
Health,...New Molecular Tests and Increased Case Volume Continue to Drive Revenu... ...ALISO VIEJO Calif. May 6 /- ...,Clarient,Reports,41%,Revenue,Increase,for,First,Quarter,2009,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
Clarient Inc
We have a whole new approach to pathology services. We are a group of dedicated people bringing comprehensive lab resources, remote pathology capabilities and cellular image analysis together for the first time.
Sr. Application Developer
Clarient, Inc. is dedicated to bring comprehensive lab resources, remote pathology capabilities and cellular image analysis together for the first time.
LIMS Finder: best site for laboratory informatics, LIMS products, LIMS news, LIMS jobs & more
ALISO VIEJO, Calif., Nov. 30 /PRNewswire-FirstCall/ -- Clarient, Inc., a technology and services resource for pathologists, oncologists and the pharmaceutical industry, and Natural Selection, Inc.
Web Sites
powered by 
Total : 36 View more »
Home [www.clarientinc.com]
www.clarientinc.com
Clarient is a leading provider of cancer diagnostic testing. ... In The News: Clarient to Present at Upcoming Healthcare Investor Conferences in New York City Read more...
Clarient Incorporated | CLRT | CLRT | TheStreet.com
www.thestreet.com
Stay informed on the latest Clarient Incorporated news. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
http://www.thestreet.com/topic/7574/clarient-incorporated.html
CLRT - Clarient Incorporated | CLRT Stock Quotes | TheStreet.com
www.thestreet.com
Get the latest CLRT - Clarient Incorporated stock market performance data. TheStreet is the source for financial market news, trading stock, quotes, and personal finance advice.
Clarient, Incorporated - Company Profiles - Resources - Portfolio ...
www.portfolio.com
Find business news, business blogs, executive career advice, business travel, business culture, company & executive profiles.
http://www.portfolio.com/resources/company-profiles/Clarient-Incorporated-3629